S

S2Medical AB (publ)
STO:S2M

Watchlist Manager
S2Medical AB (publ)
STO:S2M
Watchlist
Price: 0.0106 SEK Market Closed
Market Cap: 8.9m SEK
Section:
 

Relative Value

The Relative Value of one S2M stock under the Base Case scenario is hidden SEK. Compared to the current market price of 0.0106 SEK, S2Medical AB (publ) is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

S2M Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation Multiples

0.5
P/S
P/S
Price to Sales
0.5
vs History
95
vs Industry
70
Median 3Y
1.1
Median 5Y
1.6
Industry
2.3
More Details
Negative
P/E
P/E
Price to Earnings
N/A
vs History
vs Industry
Median 3Y
-0.9
Median 5Y
-1.3
Industry
22.4
More Details
1.5
P/OCF
P/OCF
Price to OCF
1.5
vs History
17
vs Industry
56
Median 3Y
-0.1
Median 5Y
-0.7
Industry
14.4
More Details
Negative
P/FCFE
P/FCFE
Price to FCFE
N/A
vs History
vs Industry
Median 3Y
-1.4
Median 5Y
-1.6
Industry
21.5
More Details
0.5
P/B
P/B
Price to Book Value
0.5
vs History
85
vs Industry
68
Median 3Y
1.2
Median 5Y
1.3
Industry
2.2
More Details
0.4
EV/S
EV/S
Enterprise Value to Sales
0.4
vs History
85
vs Industry
75
Median 3Y
1
Median 5Y
1.1
Industry
2.5
More Details
0.4
EV/GP
EV/GP
Enterprise Value to Gross Profit
0.4
vs History
87
vs Industry
83
Median 3Y
1.1
Median 5Y
1.6
Industry
5.1
More Details
Negative
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
N/A
vs History
vs Industry
54
Median 3Y
-0.7
Median 5Y
-0.8
Industry
12
More Details
Negative
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
N/A
vs History
vs Industry
49
Median 3Y
-0.7
Median 5Y
-0.8
Industry
17.1
More Details
1.3
EV/OCF
EV/OCF
Enterprise Value to OCF
1.3
vs History
17
vs Industry
57
Median 3Y
-0.1
Median 5Y
-0.5
Industry
14.7
More Details
1.4
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
1.4
vs History
11
vs Industry
46
Median 3Y
-0.1
Median 5Y
-0.5
Industry
18.8
More Details
0.3
EV/IC
EV/IC
Enterprise Value to IC
0.3
vs History
73
vs Industry
78
Median 3Y
0.4
Median 5Y
0.7
Industry
1.8
More Details

Multiples Across Competitors

S2M Competitors Multiples
S2Medical AB (publ) Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
SE
S2Medical AB (publ)
STO:S2M
8.9m SEK 0.5 -9 -97 -4.5
JP
Hoya Corp
TSE:7741
8.2T JPY 9.4 39.6 25 29.8
CH
Alcon AG
SIX:ALC
30.9B CHF 3.8 37.1 15.5 30.2
DK
Coloplast A/S
CSE:COLO B
127.1B DKK 4.6 35 16 19.1
US
Align Technology Inc
NASDAQ:ALGN
11.9B USD 3 31.5 14.3 18.1
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
45.8B CNY 10.1 27.8 25.5 25.5
UK
ConvaTec Group PLC
LSE:CTEC
4.7B GBP 2.7 29.1 223.6 363.3
CA
Bausch + Lomb Corp
NYSE:BLCO
6B USD 1.2 -19.7 19.6 92.4
CH
Ypsomed Holding AG
SIX:YPSN
4.3B CHF 5.5 22.3 14.5 19.7
JP
Asahi Intecc Co Ltd
TSE:7747
819.3B JPY 6.8 64.3 19.2 25.7
US
Merit Medical Systems Inc
NASDAQ:MMSI
5.1B USD 3.5 43.4 19.7 32.8
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
SE
S
S2Medical AB (publ)
STO:S2M
Average EV/EBITDA: 39.3
Negative Multiple: -97 		N/A N/A
JP
Hoya Corp
TSE:7741
25
11%
2.3
CH
Alcon AG
SIX:ALC
15.5
8%
1.9
DK
Coloplast A/S
CSE:COLO B
16
8%
2
US
Align Technology Inc
NASDAQ:ALGN
14.3
13%
1.1
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
25.5
15%
1.7
UK
ConvaTec Group PLC
LSE:CTEC
223.6
10%
22.4
CA
Bausch + Lomb Corp
NYSE:BLCO
19.6
21%
0.9
CH
Ypsomed Holding AG
SIX:YPSN
14.5
22%
0.7
JP
A
Asahi Intecc Co Ltd
TSE:7747
19.2
10%
1.9
US
Merit Medical Systems Inc
NASDAQ:MMSI
19.7
16%
1.2
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
SE
S
S2Medical AB (publ)
STO:S2M
Average EV/EBIT: 65.7
Negative Multiple: -4.5 		N/A N/A
JP
Hoya Corp
TSE:7741
29.8
N/A N/A
CH
Alcon AG
SIX:ALC
30.2
24%
1.3
DK
Coloplast A/S
CSE:COLO B
19.1
8%
2.4
US
Align Technology Inc
NASDAQ:ALGN
18.1
15%
1.2
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
25.5
11%
2.3
UK
ConvaTec Group PLC
LSE:CTEC
363.3
23%
15.8
CA
Bausch + Lomb Corp
NYSE:BLCO
92.4
59%
1.6
CH
Ypsomed Holding AG
SIX:YPSN
19.7
29%
0.7
JP
A
Asahi Intecc Co Ltd
TSE:7747
25.7
N/A N/A
US
Merit Medical Systems Inc
NASDAQ:MMSI
32.8
30%
1.1

See Also

Summary
S2M intrinsic value, competitors valuation, and company profile.
DCF Valuation
S2M stock valuation using Discount Cash Flow valuation method.
Relative Valuation
S2M stock valuation using valuation multiples.
Wall Street Estimates
S2M price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
S2M stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 302,600+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.